- Home
- CGC vs ABSI Comparison
CGC vs ABSI Comparison
Compare CGC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGC | ABSI |
|---|---|---|
| Founded | N/A | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.3M | 418.0M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CGC | ABSI |
|---|---|---|
| Price | $1.08 | $2.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | ★ 9.1M | 2.5M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.75 | 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,759,000.00 | $4,534,000.00 |
| Revenue This Year | $8.04 | $10.72 |
| Revenue Next Year | $4.17 | $313.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.77 | $2.01 |
| 52 Week High | $2.38 | $5.23 |
Technical Indicators
Market Signals| Indicator | CGC | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 37.19 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.25 | $3.29 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 26.32 | 2.94 |
Price Performance
Historical ComparisonAbout CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.